Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2

Moshe Rehavi*, Netta Roz, Abraham Weizman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

We compared the effect of chronic clozapine and haloperidol treatment on the expression of rat brain vesicular monoamine transporter (VMAT2) as well as on the membranal presynaptic transporters for serotonin, dopamine and noradrenaline. Rats were treated for 21 days with clozapine (25 mg/kg), haloperidol (0.5 mg/kg) or saline. VMAT2 expression was assessed on the protein level by high affinity [3H]dihydrotetrabenazine binding using autoradiography, and on the mRNA level by in situ hybridization. The densities of the monoamine transporters were evaluated by autoradiography using specific ligands. Clozapine administration led to an increase in [3H]TBZOH binding in the nucleus accumbens, prefrontal cortex and striatum, whereas haloperidol had no effect on VMAT2 binding capacity. The clozapine-induced increase in VMAT2 was accompanied by a parallel increase in the membrane serotonin transporter in the prefrontal cortex and the striatum. Haloperidol induced an increase in the serotonin transporter in the striatum and the core of the nucleus accumbens. The special effect of clozapine on VMAT2 expression may be relevant to its unique therapeutic advantages.

Original languageEnglish
Pages (from-to)261-268
Number of pages8
JournalEuropean Neuropsychopharmacology
Volume12
Issue number3
DOIs
StatePublished - 2002

Keywords

  • Clozapine
  • Dopamine transporter
  • Haloperidol
  • Noradrenaline transporter
  • Serotonin transporter
  • Vesicular monoamine transporter

Fingerprint

Dive into the research topics of 'Chronic clozapine, but not haloperidol, treatment affects rat brain vesicular monoamine transporter 2'. Together they form a unique fingerprint.

Cite this